The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers

BACKGROUND: After a huge efficacy of imatinib in treating patients with gastrointestinal stromal tumors (GISTs) was proven, a maximum effort was made to make a differential diagnosis between GISTs and gastrointestinal leiomyosarcomas (GI‐LMS), showing the latter to be an extremely rare tumor entity....

Descripción completa

Detalles Bibliográficos
Autores principales: Zagami, Paola, Comandone, Alessandro, Fiore, Marco, Baldi, Giacomo Giulio, Grignani, Giovanni, Vincenzi, Bruno, Gronchi, Alessandro, Antonarelli, Gabriele, Boglione, Antonella, Pennacchioli, Elisabetta, Curigliano, Giuseppe, Conforti, Fabio, De Pas, Tommaso Martino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501229/
https://www.ncbi.nlm.nih.gov/pubmed/37455549
http://dx.doi.org/10.1002/cam4.6340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501229/
https://www.ncbi.nlm.nih.gov/pubmed/37455549
http://dx.doi.org/10.1002/cam4.6340

Ejemplares similares